IO

Iovance Biotherapeutics IncNASDAQ IOVA Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

3.087

Middle

Exchange

XNAS - Nasdaq

View Full Company Analysis

Cash flow from operating activities CFO

-0.098 B

Last period CFO ,USD

-191%

CFO has decreased in 5 years


What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO of Iovance ?

Iovance`s CFO for the period ended 2024-06-30 is -0.098 B USD

View Full Company Analysis